Details for Patent: 9,309,234
Which drugs does patent 9,309,234 protect, and when does it expire?
Patent 9,309,234 protects OLINVYK and is included in one NDA.
This patent has fifty-two patent family members in twenty-four countries.
Summary for Patent: 9,309,234
| Title: | Opioid receptor ligands and methods of using and making same |
| Abstract: | This application describes compounds that can act as opioid receptor ligands, which compounds can be used in the treatment of, for example, pain and pain related disorders. |
| Inventor(s): | Dennis Yamashita, Dimitar Gotchev, Philip Pitis, Xiao-Tao Chen, Guodong Liu, Catherine C. K. Yuan |
| Assignee: | Trevena Inc |
| Application Number: | US14/712,974 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 9,309,234
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-001 | Oct 30, 2020 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION | ⤷ Start Trial | ||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-002 | Oct 30, 2020 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION | ⤷ Start Trial | ||
| Trevena | OLINVYK | oliceridine | SOLUTION;INTRAVENOUS | 210730-003 | Oct 30, 2020 | DISCN | Yes | No | ⤷ Start Trial | ⤷ Start Trial | Y | Y | MANAGEMENT OF ACUTE PAIN BY INTRAVENOUS INJECTION | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 9,309,234
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2012230761 | ⤷ Start Trial | |||
| Australia | 2017200745 | ⤷ Start Trial | |||
| Brazil | 112013024136 | ⤷ Start Trial | |||
| Canada | 2830742 | ⤷ Start Trial | |||
| China | 103702561 | ⤷ Start Trial | |||
| Cyprus | 1119057 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
